Global endocrinology market: 8% CAGR between 2012 and 2016

The Global Endocrinology Drugs market is to grow at a CAGR of 7.58
percent over the period 2012-2016. One of the key factors contributing
to this market growth is the introduction of new drugs. The Global
Endocrinology Drugs market has also been witnessing the increase in
market consolidation. However, the off-label use of the human growth
hormone could pose a challenge to the growth of this market.

The
Global Endocrinology Drugs market is witnessing the introduction of
innovative and improved drugs and formulations using various
drug-delivery technologies. The major players in the Global
Endocrinology Drugs market are concentrating on developing new
formulations using different drug-delivery routes. Hormone replacement
therapy usually involves frequent injections. Novel formulations are
using quicker and easier delivery routes than the frequent injections
involved in hormone replacement therapy. In order to increase patient
compliance, the major players in the Global Endocrinology market are
developing novel formulations using various drug-delivery technologies.

The
anticipated launch of new molecules such as PLB03002, Arimidex,
Pasireotide, and C2L is expected to drive the growth of the market
during the forecast period. PLB03002 is a new sustained-release
recombinant human growth hormone. It is an improved formulation for the
treatment of growth hormone deficiency. Pasireotide is a
multireceptor-targeting somatostatin analog. C2L is an improved
formulation of Sandostatin LAR. It is an improved formulation of
octreotide. It is under investigation for the treatment of acromegaly.
Hence, the introduction of new and better drugs is expected to drive the
growth of the market.

Companiesandmarkets.com issues news updates and report summaries covering all major industries and sectors. The service provides additional client monitoring and timely alerts to breaking industry and sector news leading the day's business headlines. News articles, written by our staff, contain additional analyst insight, providing value added insight for our readers. News updates and real-time alerts on newly-released market reports are also available from our Facebook page, Twitter feed @CandMResearch and RSS links. We also welcome inquiries from business journalists and the news media.